The aryl hydrocarbon receptor mediates degradation of estrogen receptor α through activation of proteasomes

Molecular and Cellular Biology

Volumn 23, Issue 6, 2003, Pages 1843-1855

  Wormke, Mark ^a   Stoner, Matthew ^a   Saville, Bradley ^a   Walker, Kelcey ^a   Abdelrahim, Maen ^a   Burghardt, Robert ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CALPASTATIN; CHLOROQUINE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; PROTEASOME; PROTEASOME INHIBITOR;

ARTICLE; BREAST CANCER; CANCER CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM; UTERUS CANCER;

ANIMALS; BREAST NEOPLASMS; CYCLOHEXIMIDE; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; FLAVONOIDS; HUMANS; MACROMOLECULAR SUBSTANCES; MAP KINASE SIGNALING SYSTEM; MICE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN SYNTHESIS INHIBITORS; RECEPTOR CROSS-TALK; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; TETRACHLORODIBENZODIOXIN; TRANS-ACTIVATION (GENETICS); TRANSFECTION; UBIQUITIN;

MAMMALIA; MINK CELL FOCUS-FORMING VIRUS; RODENTIA;

EID: 0037373474     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.6.1843-1855.2003     Document Type: Article

References (55)

1. Abdelrahim, M., I. Samudio, R. Smith, R. Burghardt, and S. Safe. 2002. Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J. Biol. Chem. 277:28815-28822.
2. Alarid, E. T., N. Bakopoulos, and N. Solodin. 1999. Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol. Endocrinol. 13:1522-1534.
3. Beato, M., P. Herrlich, and G. Scbutz. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857.
4. Boudjelal, M., Z. Wang, J. J. Voorhees, and G. J. Fisher. 2000. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor γ and retinoid X receptor α in human keratinocytes. Cancer Res. 60:2247-2252.
5. Brueggemeier, R. W. 1994. Aromatase inhibitors - mechanisms of steroidal inhibitors. Breast Cancer Res. Treat. 30:31-42.
6. Dace, A., L. Zhao, K. S. Park, T. Furuno, N. Takamura, M. Nakanishi, B. L. West, J. A. Hanover, and S. Cheng. 2000. Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. Proc. Natl. Acad. Sci. USA 97:8985-8990.
7. Davarinos, N. A., and R. S. Pollenz. 1999. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. J. Biol. Chem. 274:28708-28715.
8. DeMartino, G. N., and C. A. Slaughter. 1999. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274:22123-22126.
9. Duan, R., W. Porter, I. Samudio, C. Vyhlidal, M. Kladde, and S. Safe. 1999. Transcriptional activation of c-fos protooncogene by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Endocrinol. 13:1511-1521.
10. Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
11. El Khissiin, A., and G. Leclercq. 1999. Implication of proteasome in estrogen receptor degradation. FEBS Lett. 448:160-166.
12. Freemont, P. S. 2000. Ubiquitination: RING for destruction? Curr. Biol. 10:R84-R87.
13. Fuqua, S. A., J. Russo, S. E. Shackney, and M. E. Stearns. 2000. Estrogen, estrogen receptors and selective estrogen receptor modulators in human breast cancer. J. Women's Cancer 2:21-32.
14. Gillesby, B., M. Santostefano, W. Porter, Z. F. Wu, S. Safe, and T. Zacharewski. 1997. Identification of a motif within the 5′-regulatory region on pS2 which is responsible for Ap1 binding and TCDD-mediated suppression. Biochemistry 36:6080-6089.
15. Hall, J. M., J. F. Couse, and K. S. Korach. 2001. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 276:36869-36872.
16. Hannon, G. J. 2002. RNA interference. Nature 418:244-251.
17. Harborth, J., S. M. Elbashir, K. Bechert, T. Tuschl, and K. Weber. 2001. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114:4557-4565.
18. Harper, N., X. Wang, H. Liu, and S. Safe. 1994. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Mol. Cell. Endocrinol. 104:47-55.
19. Jain, S., K. M. Dolwick, J. V. Schmidt, and C. A. Bradfield. 1994. Potent transactivation domains of the Ah receptor and the Ah receptor nuclear translocator map to their carboxyl termini. J. Biol. Chem. 269:31518-31524.
20. Katzenellenbogen, J. A., B. W. O'Malley, and B. S. Katzenellenbogen. 1996. Tripartite steroid hormone receptor pharmacology - interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10:119-131.
21. Klinge, C. M., K. Kaur, and H. I. Swanson. 2000. The aryl hydrocarbon receptor interacts with estrogen receptor α and orphan receptors COUP-TFI and ERRα1. Arch. Biochem. Biophys. 373:163-174.
22. Kobayashi, A., K. Sogawa, and Y. Fujii-Kuriyama. 1996. Cooperative interaction between AhR-Arnt and Sp1 for the drug-inducible expression of CYP1A1 gene. J. Biol. Chem. 271:12310-12316.
23. Kopf, E., J.-L. Plassat, V. Vivat, H. de Thé, P. Chambon, and C. Rochette-Egly. 2000. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors α and γ through the ubiquitin-proteasome pathway. J. Biol. Chem. 275:33280- 33288.
24. Kornitzer, D., and A. Ciechanover. 2000. Modes of regulation of ubiquitin-mediated protein degradation. J. Cell Physiol. 182:1-11.
25. Krishnan, V., W. Porter, M. Santostefano, X. Wang, and S. Safe. 1995. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol. Cell. Biol. 15:6710-6719.
26. Kumar, M. B., R. W. Tarpey, and G. H. Perdew. 1999. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors: absence of a role for LXXLL motifs. J. Biol. Chem. 274:22155-22164.
27. Lange, C. A., T. Shen, and K. B. Horwitz. 2000. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. USA 97:1032-1037.
28. 3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol. Endocrinol. 13:1686-1694.
29. Lonard, D. M., Z. Nawaz, C. L. Smith, and B. W. O'Malley. 2000. The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol. Cell 5:939-948.
30. Ma, Q., and K. T. Baldwin. 2000. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activation and DNA binding of AhR. J. Biol. Chem. 275:8432-8438.
31. Ma, X., and J. G. Babish. 1993. Acute 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure results in enhanced tyrosylphosphorylation and expression of murine hepatic cyclin dependent kinases. Biochem. Biophys. Res. Commun. 197:1070-1077.
32. McDougal, A., M. Wormke, J. Calvin, and S. Safe. 2001. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective Ah receptor modulator. Cancer Res. 61:3901-3907.
33. Nguyen, T. A., D. Hoivik, J. E. Lee, and S. Safe. 1999. Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch. Biochem. Biophys. 367:250-257.
34. Pickart, C. M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:503-533.
35. Pollenz, R. S., and E. R. Barbour. 2000. Analysis of the complex relationship between nuclear export and aryl hydrocarbon receptor-mediated gene regulation. Mol. Cell. Biol. 20:6095-6104.
36. Porter, W., and S. Safe. 1998. Estrogenic and antiestrogenic compounds, p. 267-283. In A. Puga and K. B. Wallace (ed.), Molecular biology approaches to toxicology. Techbooks, Fairfax, Va.
37. Porter, W., B. Saville, D. Hoivik, and S. Safe. 1997. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol. Endocrinol. 11:1569-1580.
38. Porter, W., F. Wang, R. Duan, C. Qin, E. Castro-Rivera, and S. Safe. 2001. Transcriptional activation of heat shock protein 27 gene expression by 17β-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists: estrogenic activity of ICI 164,384. J. Mol. Endocrinol. 26:31-42.
39. Reiners, J. J. J., J. Y. Lee, R. E. Clift, D. T. Dudley, and S. P. Myrand. 1998. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. Mol. Pharmacol. 53:438-445.
40. Roberts, B. J., and M. L. Whitelaw. 1999. Degradation of the basic helix-loop-helix/Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway. J. Biol. Chem. 274:36351-36356.
41. Robertson, J. F., R. I. Nicholson, N. J. Bundred, E. Anderson, Z. Rayter, M. Dowsett, J. N. Fox, J. M. Gee, A. Webster, A. E. Wakeling, C. Morris, and M. Dixon. 2001. Comparison of the short-term biological effects of 7α-[9- (4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17β-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer. Cancer Res. 61:6739-6746.
42. Romkes, M., and S. Safe. 1988. Comparative activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and progesterone on antiestrogens in the female rat uterus. Toxicol. Appl. Pharmacol. 92:368-380.
43. Rowlands, J. C., I. J. McEwan, and J. A. Gustafsson. 1996. Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors. Mol. Pharmacol. 50:538-548.
44. Safe, S., A. McDougal, M. S. Gupta, and K. Ramamoorthy. 2001. Selective Ah receptor modulators (SAhRMs): progress towards development of a new class of inhibitors of breast cancer growth. J. Women's Cancer 3:37-45.
45. Santiso-Mere, D., T. Sone, G. M. Hilliard, J. W. Pike, and D. P. McDonnell. 1993. Positive regulation of the vitamin D receptor by its cognate ligand in heterologous expression systems. Mol. Endocrinol. 7:833-839.
46. Sheflin, L., B. Keegan, W. Zhang, and S. W. Spaulding. 2000. Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels. Biochem. Biophys. Res. Commun. 275:144-150.
47. Smith, C. L., and B. W. O'Malley. 1999. Evolving concepts of selective estrogen receptor action: from basic science to clinical applications. Trends Endocrinol. Metab. 10:299-300.
48. Stancovski, I., H. Gonen, A. Orian, A. L. Schwartz, and A. Ciechanover. 1995. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol. Cell. Biol. 15:7106-7116.
49. Stenoien, D. L., K. Patel, M. G. Mancini, M. Dutertre, C. L. Smith, B. W. O'Malley, and M. A. Mancini. 2001. FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent. Nat. Cell Biol. 3:15-23.
50. Tsurumi, C., N. Ishida, T. Tamura, A. Kakizuka, E. Nishida, E. Okumura, T. Kishimoto, M. Inagaki, K. Okazaki, and N. Sagata. 1995. Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol. Cell. Biol. 15:5682-5687.
51. Umbreit, T. H., and M. A. Gallo. 1988. Physiological implications of estrogen receptor modulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Lett. 42:5-14.
52. Wijayaratne, A. L., and D. P. McDonnell. 2001. The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J. Biol. Chem. 276:35684-35692.
53. Wijayaratne, A. L., S. C. Nagel, L. A. Paige, D. J. Christensen, J. D. Norris, D. M. Fowlkes, and D. P. McDonnell. 1999. Comparative analyses of mechanistic differences among antiestrogens. Endocrinology 140:5828-5840.
54. Wormke, M., M. Stoner, B. Saville, and S. Safe. 2000. Crosstalk between estrogen receptor α and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteosomes. FEBS Lett. 478:109-112.
55. Zhu, J., M. Gianni, E. Kopf, N. Honore, M. Chelbi-Alix, M. Koken, F. Quignon, C. Rochette-Egly, and H. de The. 1999. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins. Proc. Natl. Acad. Sci. USA 96:14807-14812.